|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 6 1305-1315, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
PH Francis-West, A Abdelfattah, P Chen, C Allen, J Parish, R Ladher, S Allen, S MacPherson, FP Luyten and CW Archer
Department of Craniofacial Development, Guy's, King's and St Thomas' School of Dentistry, Guy's Tower, Floor 28, London Bridge, London, SE1 9RT, UK. pfrancis@hgmp.mrc.ac.uk
Mutations in GDF-5, a member of the TGF-beta superfamily, result in the autosomal recessive syndromes brachypod (bp) in mice and Hunter-Thompson and Grebe-type chondrodysplasias in humans. These syndromes are all characterised by the shortening of the appendicular skeleton and loss or abnormal development of some joints. To investigate how GDF-5 controls skeletogenesis, we overexpressed GDF-5 during chick limb development using the retrovirus, RCASBP. This resulted in up to a 37.5% increase in length of the skeletal elements, which was predominantly due to an increase in the number of chondrocytes. By injecting virus at different stages of development, we show that GDF-5 can increase both the size of the early cartilage condensation and the later developing skeletal element. Using in vitro micromass cultures as a model system to study the early steps of chondrogenesis, we show that GDF-5 increases chondrogenesis in a dose-dependent manner. We did not detect changes in proliferation. However, cell suspension cultures showed that GDF-5 might act at these stages by increasing cell adhesion, a critical determinant of early chondrogenesis. In contrast, pulse labelling experiments of GDF-5-infected limbs showed that at later stages of skeletal development GDF-5 can increase proliferation of chondrocytes. Thus, here we show two mechanisms of how GDF-5 may control different stages of skeletogenesis. Finally, our data show that levels of GDF-5 expression/activity are important in controlling the size of skeletal elements and provides a possible explanation for the variation in the severity of skeletal defects resulting from mutations in GDF-5.
This article has been cited by other articles:
|
|
 |
|
  K. Chapman, A. Takahashi, I. Meulenbelt, C. Watson, J. Rodriguez-Lopez, R. Egli, A. Tsezou, K. N. Malizos, M. Kloppenburg, D. Shi, et al. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility Hum. Mol. Genet., May 15, 2008; 17(10): 1497 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujimura, Y. Terai, N. Ishiguro, M. Miya, M. Nishida, and N. Okada Heterotypy in the N-Terminal Region of Growth/Differentiation Factor 5 (GDF5) Mature Protein during Teleost Evolution Mol. Biol. Evol., May 1, 2008; 25(5): 797 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Masuya, K. Nishida, T. Furuichi, H. Toki, G. Nishimura, H. Kawabata, H. Yokoyama, A. Yoshida, S. Tominaga, J. Nagano, et al. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice Hum. Mol. Genet., October 1, 2007; 16(19): 2366 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Southam, J. Rodriguez-Lopez, J. M. Wilkins, M. Pombo-Suarez, S. Snelling, J. J. Gomez-Reino, K. Chapman, A. Gonzalez, and J. Loughlin An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage Hum. Mol. Genet., September 15, 2007; 16(18): 2226 - 2232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Thomas, D. Prakash, K. Weih, and M. Moos Jr. CDMP1/GDF5 Has Specific Processing Requirements That Restrict Its Action to Joint Surfaces J. Biol. Chem., September 8, 2006; 281(36): 26725 - 26733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Meech, D. B. Edelman, F. S. Jones, and H. P. Makarenkova The homeobox transcription factor Barx2 regulates chondrogenesis during limb development Development, May 1, 2005; 132(9): 2135 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Demirhan, S Turkmen, G C Schwabe, S Soyupak, E Akgul, D Tastemir, D Karahan, S Mundlos, and K Lehmann A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies J. Med. Genet., April 1, 2005; 42(4): 314 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sammar, S. Stricker, G. C. Schwabe, C. Sieber, A. Hartung, M. Hanke, I. Oishi, J. Pohl, Y. Minami, W. Sebald, et al. Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2 Genes Cells, December 1, 2004; 9(12): 1227 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Guo, T. F. Day, X. Jiang, L. Garrett-Beal, L. Topol, and Y. Yang Wnt/{beta}-catenin signaling is sufficient and necessary for synovial joint formation Genes & Dev., October 1, 2004; 18(19): 2404 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Garciadiego-Cazares, C. Rosales, M. Katoh, and J. Chimal-Monroy Coordination of chondrocyte differentiation and joint formation by {alpha}5{beta}1 integrin in the developing appendicular skeleton Development, October 1, 2004; 131(19): 4735 - 4742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lehmann, P. Seemann, S. Stricker, M. Sammar, B. Meyer, K. Suring, F. Majewski, S. Tinschert, K.-H. Grzeschik, D. Muller, et al. From the Cover: Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2 PNAS, October 14, 2003; 100(21): 12277 - 12282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Buxton, B. Hall, C. W. Archer, and P. Francis-West Secondary chondrocyte-derived Ihh stimulates proliferation of periosteal cells during chick development Development, October 1, 2003; 130(19): 4729 - 4739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Anakwe, L. Robson, J. Hadley, P. Buxton, V. Church, S. Allen, C. Hartmann, B. Harfe, T. Nohno, A. M. C. Brown, et al. Wnt signalling regulates myogenic differentiation in the developing avian wing Development, August 1, 2003; 130(15): 3503 - 3514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Canalis, A. N. Economides, and E. Gazzerro Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton Endocr. Rev., April 1, 2003; 24(2): 218 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Miller, D. Yelon, D. Y. R. Stainier, and C. B. Kimmel Two endothelin 1 effectors, hand2 and bapx1, pattern ventral pharyngeal cartilage and the jaw joint Development, April 1, 2003; 130(7): 1353 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Church, T. Nohno, C. Linker, C. Marcelle, and P. Francis-West Wnt regulation of chondrocyte differentiation J. Cell Sci., March 14, 2003; 115(24): 4809 - 4818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rivas and F. Shapiro Structural Stages in the Development of the Long Bones and Epiphyses : A Study in the New Zealand White Rabbit J. Bone Joint Surg. Am., January 1, 2002; 84(1): 85 - 100. [Abstract] [Full Text]
|
|
|
|
|
|
P. Buxton, C. Edwards, C. W. Archer, and P. Francis-West Growth/Differentiation Factor-5 (GDF-5) and Skeletal Development J. Bone Joint Surg. Am., April 1, 2001; 83(90010): S23 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Buxton, C. Edwards, C. W. Archer, and P. Francis-West Growth/Differentiation Factor-5 (GDF-5) and Skeletal Development J. Bone Joint Surg. Am., March 1, 2001; 83(1_suppl_1): S23 - S30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Baur, J. Mai, and S. Dymecki Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity Development, January 2, 2000; 127(3): 605 - 619. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Fujii, K. Takeda, T. Imamura, H. Aoki, T. K. Sampath, S. Enomoto, M. Kawabata, M. Kato, H. Ichijo, and K. Miyazono Roles of Bone Morphogenetic Protein Type I Receptors and Smad Proteins in Osteoblast and Chondroblast Differentiation Mol. Biol. Cell, November 1, 1999; 10(11): 3801 - 3813. [Abstract] [Full Text]
|
|
